Evan T Keller

Title: The Innovative Contributions of Evan T Keller

Introduction

Evan T Keller is a prominent inventor based in Ann Arbor, MI (US). He has made significant strides in the field of cancer research, particularly focusing on methods for detecting and inhibiting metastasis. With a total of 2 patents to his name, Keller's work is paving the way for advancements in cancer diagnostics and therapeutics.

Latest Patents

Keller's latest patents include groundbreaking inventions that address critical issues in cancer treatment. One of his notable patents is titled "Compositions and methods for detecting cancer and for inhibiting metastasis." This invention relates to methods for detecting vimentin expression and secretion, specifically in prostate cancer. It also provides innovative approaches for inhibiting metastasis by altering vimentin expression and activity. Another significant patent is "Systems and methods for detecting and regulating metastasis," which focuses on cancer diagnostics and therapeutics, utilizing RKIP cancer markers and pathway modulators. This invention aims to enhance the diagnosis and treatment of prostate cancers.

Career Highlights

Evan T Keller is affiliated with the University of Michigan, where he contributes to cutting-edge research in cancer biology. His work has garnered attention for its potential impact on improving cancer treatment outcomes. Keller's dedication to innovation in this field is evident through his research and patent contributions.

Collaborations

Keller collaborates with esteemed colleagues, including David M Markovitz and Nirit Mor-Vaknin. These partnerships enhance the research efforts and broaden the scope of their work in cancer diagnostics and therapeutics.

Conclusion

Evan T Keller's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches to detecting and inhibiting cancer metastasis are crucial in the ongoing battle against this disease.